近年来，生物制造已作为多数国家提升经济竞争力的着力点，也是我国继绿色制造、智能制造后，推进制造强国建设的又一重要抓手。同时，各地政府 地区通过结合自身优势力争实现合成生物"研发－转化－产业—集群"协同发展，发挥新质生产力 作用。 8月20-22日 将于 浙江·宁波 举 办 第四届合成生物与绿色生物制造大会 (简称： SynBioCon 2 025 ) 。大会 聚焦" 1+4 " ： AI+生 物智造 这一大热门赛道； 绿色化工与新材料、 未来食品、未来农业和美妆原料四大应用领域 ，邀请国 际领先企业、代表性产业化专家、政府、园 区、资本、协会和联盟等各方共探 "十五五"生物制造产业发展趋势 ； 哪些革新技术和产品将给生物制造产业带来持续的生命力 ； 并致力于 促进科技 成果转移转化 、 产品 规模 化与人才挖掘 。 一、组织机构 主办单位： 宁波德泰中研信息科技有限公司（ DT 新材料） 协办 单位： 宁波酶赛生物工程有限公司 二、大会亮点 亮点一 ： 大会论坛、闭门活动洞察"十五五"生物制造发展趋势！探索新产品、新技术、新落地、 新合作！ 亮点二： 青年创新技术与价值分享、人才对接与合作！ 亮点三： 1 0 ...

SynBio团队 | 史硕博 酿酒酵母作为一个平台细胞工厂，已用于生产多种高价值化合物。近年来，合成生物学创新工具推动了酵母细胞工厂的快速发展，使我们能够 高效地编辑生物的遗传系统，并"重新编程"基因、回路、途径和复杂代谢网络等（图1）。 【SynBioCon】 获悉，2025年6月，BioDesign Research在线发表了 北京化工大学 史硕博团队 题为Innovative tools for customized yeast cell factory的前瞻性论文，本论文展望和介绍了酵母合成生物学创新工具的最新重大进展。这些工具包括基因组编辑工具、计算工具、 适应性实验室进化以及生物DNA元件的标准化，旨在为定制化酵母细胞工厂的新型、有效和高效开发提供实用指南。 图1 定制酵母细胞工厂的创新工具概览 计算工具，包括代谢建模和模拟以及组学技术的整合，能够指导合理的工程策略和预期的通量调节。目前，已经构建了基于基因组规模的化学 计量模型，生成了基因组规模代谢模型（GEMs），并在酵母代谢工程中得到了广泛应用。大规模动力学模型在设计、预测和理解酵母的代谢 反应中起着至关重要的作用。在此背景下，代谢控制分析（ ...

6月24日，北汽福田在马达加斯加首都塔那那利佛会展中心向马达加斯加总统拉乔利纳递交 312台客车钥匙。 作为2024年中非合作论坛北京峰会精神的重要成果转化，这是中非共建"一带一路"在绿色交 通领域合作的新里程碑，标志着中马共建"一带一路"合作迈入高质量发展新阶段。 高度认可，深度合作 交车仪式上，拉乔利纳总统先生发表致辞，他首先对北汽福田为改善马达加斯加交通基础设 施、提升公共服务水平所做出的贡献表示衷心感谢，高度认可了北汽福田客车卓越的产品品质 和专业的团队。他表示："在我当选总统时，我向马达加斯加3100万人民庄重承诺，让大家坐 在黄金上。2024年访问北汽福田时，为马达加斯加定制了312台客车。现在北汽福田客车已 经陆续抵达马达加斯加，我非常高兴。希望与北汽福田保持深度合作，双方携手将马达加斯加 的公共交通服务水平提升至新的高度，让广大人民坐在'钻石'上，真正体验钻石品质，完成我 对人民的承诺。" 北汽福田海外事业部业务副总裁刘光华表示，北汽福田作为中国品种最全、规模最大的商用车 企业，深感荣幸能为马达加斯加的交通发展贡献福田智慧，并将一如既往做好服务保障。为全 力保障车辆高效稳定运营，北汽福田已派遣 ...

点击更多阅读 ： 工信部又发文，事关非粮生物基材料产业！ 在当今发酵行业，碳源成本问题一直困扰着众多企业。传统碳源多依赖于粮食作物，不仅价格高昂、波动频繁，还面临着与民争粮的矛盾。与此同时， 我国政策逐渐重视非粮生物基产业布局。 突破非粮碳源的生物制造技术与相关企业受到行业高度关注。 其中， 青岛碧沃德生物科技有限公司 凭借多年 生物柴油行业 积累的技术与资源，突破常规，研发出 滤膜碳源 和 合生甘霖碳源 两种新型非粮碳源， 为发酵行业带来全新变革。 传统发酵碳源主要来源于糖类，如葡萄糖等，价格居高不下且波动大。 以 PHA 生产为例，仅碳源成本就占生产过程的 40%-50% ，每千克生产成本高达 2-8 美元 。这不仅增加了企业的生产成本，也给粮食安全带来了潜在风险。 青岛碧沃德生物科技有限公司另辟蹊径，从油脂行业副产物中寻找解决方案。公司改进传统生产工艺，开发出滤膜碳源和合生甘霖碳源两种新型非粮碳 源。 这两种碳源以乙酸钠和丙三醇为主要成分，含有多种促进微生物生长的小分子有机酸、维生素等营养成分，适用多种微生物培养 。它们不仅降低了对 粮食作物的依赖，还降低了碳源成本，稳定供应市场，符合 RED Ⅲ欧盟先 ...

DT产业研究院 | 郭凯教授 我国就有多个生物基材料产业化极为成功的科研团队，南京工业大学 K&k团队就是 其中之一。 K&k团队 开发的新型生物基聚氨酯、聚酯、尼龙、氨纶、助剂等新型高性能生物基材料，累计50余 万吨/年产业化 。 1. 结构可实现精准调控 近日， 南京工业大学副校长 K&k团队负责人 郭凯教授 在 2025首届生物有机合成与生物制造产业大 会上做了题为《 生物基材料工作思考 》的演讲。 DT新材料产业研究院 对此做了部分要点梳理，如内容整理有偏颇，欢迎指正。 传统石化材料（如聚醚型氨酯）结构单一、改性困难，而植物基聚氨酯可通过分子设计实现精准调 控。例如： 利用植物源的 羟基、氨基、羧基等活性基团，构建多样化聚合物网络； 保留天然大分子共价键结构，避免传统工艺对生物质的"切割-重组"损耗。 01 抛开环保因素，对比性能，生物基 VS 石油基究竟有哪些优势？ 2. 原料的天然禀赋 生物质富含合成所需的活性官能团（如氨基酸、糖类、木质素等），显著优于石化原料。 郭凯教授说： "传统化工合成氨工艺仍面临选择性差、氧化安全性低等挑战，而生物质天然基团可直 接参与高效聚合。" 3. 资源循环闭环 0 ...

因此,在论坛赞助用车品牌的选择上,势必会选择那些拥有强大品牌实力的头部企业;同时,在论坛赞助用 车也必定是严守"精挑细选",产品的颜值、品质、性能、体验等方面都必须经得起全方位、严格地检 验。因此,无论是爱玛荣膺赞助用车品牌,还是零动M20跻身赞助用车,无不彰显出爱玛科技国际化的品牌 形象和卓越的产品实力与本次论坛议题与办会理念的高度契合,堪称是再次擦亮了国际交流中的"中国智 造名片"。 近几年,随着国际形势变化带来的传统能源价格上涨。在全球市场上,两轮电动车获得了越来越多的关注 与青睐,根据海外研究机构MRFR发布的报告,从2023年至2030年,全球两轮电动车市场的年复合增长率将 达到34.57%,规模将突破1000亿美元大关。面对如此广阔的蓝海市场,作为全球最大的两轮车生产基地,同 时也是全球最大的两轮电动车消费国和出口国,我国新能源产业链的先发优势造就了中国企业在这个千 亿级赛道上的领先地位。 2025年夏季达沃斯论坛(新领军者年会)将于6月24日至26日在中国天津举行。作为中国电动两轮车行业 头部品牌与根植天津的"本土"企业,爱玛科技（603529）正式成为2025天津夏季达沃斯赞助用车品牌,爱 玛 ...

Core Viewpoint - The automotive industry is shifting towards self-reliance and innovation in response to supply chain disruptions, with companies like Li Auto and Xiaomi leading the charge through self-developed technologies and systems [1][2][3]. Group 1: Technological Advancements - Li Auto has developed its own intelligent manufacturing system, "Li-MOS," which manages the entire production cycle of vehicles, achieving 100% automation in key processes [1][5]. - The "Star Ring OS" developed by Li Auto has shown significant performance improvements, such as a 7-meter reduction in emergency braking distance at 120 km/h and a doubling of response speed [2]. - Xiaomi's factory features over 700 robots and has implemented a leading integrated die-casting production line, enhancing manufacturing efficiency [1]. Group 2: Industry Growth and Economic Impact - The automotive and transportation industry in Beijing is projected to exceed 440 billion yuan in output value in 2024, with a year-on-year growth of over 15% [1]. - In 2024, the production volume of new energy vehicles in Beijing is expected to reach 294,000 units, marking a nearly threefold increase [6]. Group 3: Collaboration and Ecosystem Development - Li Auto and Xiaomi are collaborating with local suppliers to develop advanced technologies, such as the "magic carpet air suspension," which was previously a luxury feature [3]. - The establishment of the Beijing Intelligent Connected Vehicle Innovation Fund aims to foster collaboration between companies and research institutions to advance key technologies in the sector [7]. Group 4: Strategic Location and Resources - Beijing's automotive industry benefits from a strong manufacturing base, with major production facilities and R&D centers concentrated in areas like Shunyi and Economic Development Zones [6]. - Both companies attribute their growth to Beijing's favorable policy environment, industrial foundation, and access to talent and technology [7].

Core Viewpoint - The article discusses the innovative approach of Yike Biotech in reducing the cost of PHA (polyhydroxyalkanoates) production to compete with petroleum-based materials, emphasizing the use of non-food plant oils as raw materials [3][4][9]. Group 1: Industry Background - The biodegradable materials market, including PLA and PBAT, has faced challenges such as overcapacity and performance limitations, leading to a decline in production rates [6][7]. - PHA is highlighted for its advantages, including marine biodegradability, heat resistance up to 100°C, and excellent barrier properties, with the global market expected to reach $367 million by 2030 [6][8]. Group 2: Company Overview - Yike Biotech was founded in June 2025 by Dr. Wilson Ling, who aims to revolutionize PHA production using non-food oils, specifically Pongamia oil, to significantly lower costs [9][10]. - The company has completed laboratory and pilot-scale validations of its production process and is the first globally to hold a PCT patent for PHA production [37]. Group 3: Cost Reduction Strategy - The raw material cost constitutes over 50% of PHA production costs, making it essential to lower these costs. Traditional sugar-based routes have a conversion rate of only 30%, leading to high costs [27][28]. - By using Pongamia oil, which has a conversion rate of over 80%, Yike Biotech can reduce PHA production costs by 30-50% compared to sugar-based methods [36]. Group 4: Technical and Market Development - Yike Biotech plans to focus on medical products for the Australian market, where demand is high, and the approval process is faster compared to other regions [38]. - The company aims to establish a production line in China that can replace 15,000 to 20,000 tons of petroleum-based plastics annually, with plans for further expansion [39].

Core Insights - BYD's total sales in 16 European countries surpassed Tesla's in May 2025, with a total of 10,199 vehicles sold in key markets including the UK, France, Germany, Italy, and Spain, leading Tesla by 6,619 vehicles [1][3] - The company's overseas sales reached a record high of 88,640 vehicles in May, representing a year-on-year growth of 133.6%, while the export volume from January to May reached 374,200 units, up 112.3% year-on-year [3][5] Group 1: Sales Performance - In the UK, BYD's May sales surged by 408% year-on-year to 3,025 vehicles, while Tesla's sales dropped by over 45% [5] - In Germany, BYD's sales in May reached 1,857 vehicles, an increase of 824% year-on-year, surpassing Tesla for two consecutive months [5] - In Italy, BYD sold nearly 2,000 vehicles, leading Tesla's 850 vehicles, while in Spain, BYD's sales of 2,434 vehicles were three times that of Tesla [5] Group 2: Market Expansion Strategies - BYD overcame initial challenges in the UK by increasing dealer engagement, conducting product test drives, and developing localized marketing strategies, resulting in a significant increase in dealer partnerships [9] - In France, BYD's local sales team utilized test drives to improve consumer trust in "Chinese manufacturing," leading to higher conversion rates [9] - Since entering Europe in early 2021, BYD's annual registrations have skyrocketed from just over 1,000 to nearly 60,000 in 2024, marking a growth of nearly 60 times [10] Group 3: Global Market Presence - BYD's success is not limited to Europe; in the Asia-Pacific region, the company has also outperformed Tesla in markets such as Singapore, Malaysia, Thailand, and Japan [10] - In Singapore, BYD has maintained its position as the top-selling passenger car brand for the first five months of the year [10] - The company has also launched its high-end brand, Tengshi, in Malaysia, achieving sales of 1,148 vehicles in May [10] Group 4: Technological and Strategic Advancements - BYD's global expansion has been supported by overcoming various challenges, including tariff barriers and production capacity issues, through establishing overseas factories and optimizing logistics [11] - The company has received international recognition for its advanced technologies, such as DM Super Hybrid and MW Flash Charging, which have contributed to its competitive product matrix [11][12] - BYD's recent launch of the Dolphin model in 15 European countries highlights its strategic entry into the small electric vehicle market, which is highly sought after by European consumers [11]

全球政策进展 | 上海市 2025 年度关键技术研发计划 "合成生物学 "项目立项清单 | 序号 | 1 | | --- | --- | | 项目编号 | 25HC2810100 | | | 基于喷墨打印微阵列芯片的高通量高精度 | | 项目名称 | 低成本长片段核酸合成 | | 项目承担单位 | 上海迪赢生物科技有限公司 | | 项目负责人 | 张满仓 | | 项目实施周期 | 2025.08.01-2028.07.31 | | 序号 | 2 | | 项目编号 | 25HC2810200 | | 项目名称 | 高通量长片段 DNA 酶促合成系统研发 | | 项目承担单位 | 上海人工智能研究院有限公司 | | 项目负责人 | 夏 凯 | | 项目实施周期 | 2025.08.01-2028.07.31 | | 序号 | 3 | 项目编号 25HC2810300 项目名称 重要天然产物生物合成功能元件挖掘及共 享元件库的构建 项目承担单位 上海中医药大学 项目负责人 陈万生 项目实施周期 2025.08.01-2028.07.31 序号 4 项目编号 25HC2810400 项目名称 生物合成新元件的挖掘表征 ...